Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
-7.91%
Shrank
—
—
Shrank
—
1 Year
Score—
Net Growth-7.91%
Net TrendShrank
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
—
50.76%
60%
—
—
Never
—
5 Years
Score—
Net Growth50.76%
Net Trend60%
Net Income Consistency—
Rev Growth—
Rev TrendNever
Revenue Consistency—
Relmada Therapeutics Inc fundamental performance
Across Relmada Therapeutics Inc's full reported history, from 2014 to 2025, net income went from -$ 20M to -$ 57M. Revenue increased in 0% of the years measured; net income in 33%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 4.72 | — |
1 Year2025-08-12 | $ 0.59 | 8x |
5 Years2021-08-12 | $ 23.65 | -80.04% |
10 Years2016-08-12 | $ 5.60 | -15.71% |
All Time2014-10-09 | $ 60.40 | -92.19% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2014-10-09 |
|---|---|---|---|---|---|
| Price | $ 4.72 | $ 0.59 | $ 23.65 | $ 5.60 | $ 60.40 |
| Return | — | 8x | -80.04% | -15.71% | -92.19% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 61M | $ 217M |
| 2025 | $ 0.00 | -$ 57M | $ 93M |
| 2024 | $ 0.00 | -$ 79M | $ 44M |
| 2023 | $ 0.00 | -$ 98M | $ 96M |
| 2022 | $ 0.00 | -$ 157M | $ 148M |
| 2021 | $ 0.00 | -$ 125M | $ 211M |
| 2020 | $ 0.00 | -$ 59M | $ 117M |
| 2019 | -$ 15M | $ 116M | |
| 2018 | $ 0.00 | -$ 8M | $ 2M |
| 2017 | -$ 6M | $ 1M | |
| 2016 | -$ 2M | $ 8M | |
| 2015 | -$ 20M | $ 22M | |
| IPO2014 | -$ 20M | $ 22M |
Explore beyond RLMD
You're looking at Relmada Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
